Markets:

Overview

News

Currencies

International

Treasuries

Forte Biosciences, Inc. - Common Stock (NQ:FBRX)

42.26 +5.55 (+15.14%)

Streaming Delayed Price Updated: 12:49 PM EDT, Jul 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Forte Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Forte Biosciences' FB102 Hits Key Goal in Vitiligo Study, Shows Durable Improvement ↗

Today 10:02 EDT

Forte Biosciences (NASDAQ:FBRX) said FB102 showed statistically significant improvement in a small placebo-controlled vitiligo study, with Chief Executive Officer Paul Wagner highlighting continued...

Via MarketBeat

Which stocks are experiencing notable movement on Thursday? ↗

July 09, 2026

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 09, 2026

Gainers Virax Biolabs Group (NASDAQ:VRAX) shares rose 178.9% to $8.87 during Thursday's regular session. The market value of their outstanding shares is at $2.5 million. Forte Biosciences (NASDAQ:FBRX)...

Via Benzinga

Let's take a look at the stocks that are in motion in today's session. ↗

July 09, 2026

Via Chartmill

FBRX Stock Earnings: Forte Biosciences Reported Results for Q1 2024 ↗

May 13, 2024

Forte Biosciences just reported results for the first quarter of 2024.

Via InvestorPlace

FBRX Stock Earnings: Forte Biosciences Reported Results for Q4 2023 ↗

March 19, 2024

Forte Biosciences just reported results for the fourth quarter of 2023.

Via InvestorPlace

Which stocks are experiencing notable movement on Thursday? ↗

April 09, 2026

Via Chartmill

There are notable gap-ups and gap-downs in today's session. ↗

April 09, 2026

Via Chartmill

Forte Biosciences Tops Q2 Loss Forecasts ↗

August 14, 2025

Via The Motley Fool

Topics Intellectual Property

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 25, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 25, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 24, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 19, 2025

Via Benzinga

Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

May 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 25, 2025

Via Benzinga

Why Forte Biosciences (FBRX) Stock Is Trading Lower ↗

December 16, 2024

Forte Biosciences shares are trading lower by 13.6% Monday afternoon. The company announced plans for the periodic resale of up to 9.5 million common stock shares by selling stockholders.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 20, 2024

Via Benzinga

Forte Biosciences Shares Are Soaring Today: What's Going On? ↗

November 20, 2024

Forte Biosciences Inc. (NASDAQ: FBRX) shares are trading higher Wednesday. The company announced a $53 million private placement to fund the development of its autoimmune-focused drug candidate, FB102....

Via Benzinga

Crude Oil Moves Lower; Williams-Sonoma Shares Gain After Q3 Results ↗

November 20, 2024

Via Benzinga

Nasdaq Tumbles Over 100 Points; TJX Earnings Top Views ↗

November 20, 2024

Via Benzinga

US Stocks Mostly Lower; Target Posts Downbeat Earnings ↗

November 20, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 26, 2024

Via Benzinga

FBRX Stock Earnings: Forte Biosciences Misses EPS for Q2 2024 ↗

August 14, 2024

FBRX stock results show that Forte Biosciences missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 15, 2023

Via Benzinga

Research Frontiers And 3 Other Stocks Under $1 Insiders Are Buying ↗

December 13, 2023

The Dow Jones index closed higher by over 150 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.